Fintel · Oct 23, 2026
AC
NASDAQ · ACH
Accendra Health, Inc.
Healthcare · Medical - Distribution
$0.25
Up+$0.02 (+9.10%)
Updated Nov 1, 2026, 8:46 PM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 187.18M
- P/E ratio
- -0.17
- Dividend yield
- 0.00%
- 52-week range
- $0.19 – $4.69
- Volume
- 1.55M
- Avg. volume
- 1.59M
Price performance · ACH
ACH price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
ACH closed at $0.25 after 20 trading sessions, down 43.64% for the selected period.
- Last close
- $0.25
- Period change
- -43.64%
- Period low
- $0.20
- Period high
- $0.47
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $0.2299 | $0.2542 | $0.2299 | $0.2542 | 1.55M |
| Oct 29, 2026 | $0.23 | $0.24 | $0.2227 | $0.233 | 1.82M |
| Oct 28, 2026 | $0.20 | $0.233 | $0.194 | $0.233 | 1.26M |
| Oct 27, 2026 | $0.208 | $0.213 | $0.1954 | $0.2031 | 1.46M |
| Oct 26, 2026 | $0.21 | $0.2301 | $0.198 | $0.2029 | 2.53M |
| Oct 23, 2026 | $0.2032 | $0.2173 | $0.191 | $0.2173 | 2.06M |
| Oct 22, 2026 | $0.212 | $0.2244 | $0.20 | $0.2108 | 2.24M |
| Oct 21, 2026 | $0.26 | $0.26 | $0.217 | $0.2188 | 2.45M |
| Oct 20, 2026 | $0.22 | $0.2628 | $0.216 | $0.2554 | 4.46M |
| Oct 19, 2026 | $0.2351 | $0.2495 | $0.1971 | $0.2202 | 4.79M |
| Oct 16, 2026 | $0.2705 | $0.29 | $0.2169 | $0.235 | 2.95M |
| Oct 15, 2026 | $0.315 | $0.3275 | $0.2615 | $0.2615 | 1.77M |
| Oct 14, 2026 | $0.32 | $0.3299 | $0.2734 | $0.3128 | 4.24M |
| Oct 13, 2026 | $0.3932 | $0.3932 | $0.3151 | $0.3151 | 2.28M |
| Oct 12, 2026 | $0.44 | $0.44 | $0.3849 | $0.3905 | 1.19M |
| Oct 9, 2026 | $0.432 | $0.4493 | $0.42 | $0.428 | 681.11K |
| Oct 8, 2026 | $0.4759 | $0.4861 | $0.435 | $0.4432 | 1.39M |
| Oct 7, 2026 | $0.47 | $0.4894 | $0.44 | $0.4729 | 1.5M |
| Oct 6, 2026 | $0.4639 | $0.5015 | $0.4421 | $0.4661 | 2.32M |
| Oct 5, 2026 | $0.51 | $0.5304 | $0.45 | $0.451 | 1.56M |
Latest ACH news
The latest Smart Investors Daily articles mentioning ACH.
Stock researchCompany · Overview
Company
Market Activity
Research & News
ACH research
Overview
Company profile and research snapshot.
Company profile
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Hold
- Average target
- $12.39
- Implied upside
- —
- Analysts
- 2
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | UBS | Neutral | — |
| Aug 11, 2026 | Citigroup | Neutral | — |
| Jul 24, 2026 | Citigroup | Buy | — |
| May 12, 2026 | UBS | Neutral | — |
| May 12, 2026 | Citigroup | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 22, 2026
Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference Call
RICHMOND, Va., October 22, 2026--Accendra Health, Inc. (NYSE: ACH) (the "Company") plans to release financial results for the third quarter of 2026 on Thursday, November 5, 2026, after trading ends on the New York Stock Exchange.
Benzinga · Oct 14, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 13.3% to $0.55 during Wednesday's after-market session. Impact BioMedical (AMEX:IBO) stock rose 10.77% to $3.77. The company's market cap stands at
Yahoo · Oct 9, 2026
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
RICHMOND, Va., October 09, 2026--Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the "Notice") from the New York Stock Exchange (the "NYSE") notifying the Company that it is not in compliance with the NYSE’s continued listing standards because the average closing price of the Company’s Class A Common Stock (the "Common Stock") was less than $1.00 per share over a consecutive 30 trading-day period. The Notice does not result in the im
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
